Demonstration of relative bioavailability of newly developed and innovator drug metaxalone 800 mg in healthy subjects under fed condition

• Príomhchruthaitheoirí: Socorrina Colaco (Údar), N Ramesh (Údar), Ramakrishna Shabaraya (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

The notable unbiased of this research work was to evaluate the well-being and effectiveness of metaxalone by administering the newly developed test and reference drug. A two-period, two-categorization, crossover bioavailability study in fed conditions. Eleven participants were dosed and completed th...